ControversiesChallengesConsensus
}

CX 2020 LIVE features key registry data on EVAR durability with EXCLUDER Conformable AAA Endoprosthesis

2020-06-02T09:27:26+01:00

Data from three global, real-world registries, GREAT, ExCeL and BSET-CLEVAR, evaluating the Excluder Conformable abdominal aortic aneurysm (AAA) Endoprosthesis with Active Control System, were shared online during the CX 2020 LIVE virtual, vascular conference. Broadcast to a global audience at the conclusion of the second […]

CX 2020 LIVE features key registry data on EVAR durability with EXCLUDER Conformable AAA Endoprosthesis2020-06-02T09:27:26+01:00

Covered endoprostheses gain key role in management of aortoiliac occlusive disease

2020-06-02T08:57:44+01:00

Michele Antonello (top) chairs the discussion, following the Industry Symposium, with Amer Zanabili and Bella Huasen.

The first session of CX 2020 LIVE also featured an Industry Symposium titled “Endovascular treatment of complex aortoiliac occlusive disease” (sponsored by Gore). Chaired by Michele Antonello […]

Covered endoprostheses gain key role in management of aortoiliac occlusive disease2020-06-02T08:57:44+01:00

First case experience presented with next generation conformable EVAR device

2018-04-27T09:29:05+01:00

CX delegates were presented data from the first 10 EVAR patients treated using a new conformable device, the Gore Excluder conformable abdominal aortic aneurysm endoprosthesis with active control system, yesterday.

Robert Rhee (Brooklyn, New York), the national principal investigator of the US investigational device exemption (IDE) trial for […]

First case experience presented with next generation conformable EVAR device2018-04-27T09:29:05+01:00
Go to Top